Prenatally buprenorphine-exposed children: health to 3 years of age.
about
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.Treating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceConsequences of prenatal opioid use for newborns.Maternal Use of Opioids During Pregnancy and Congenital Malformations: A Systematic Review.A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children.Monitoring neonatal abstinence syndrome in buprenorphine-exposed in vitro fertilization twins: A case study.
P2860
Prenatally buprenorphine-exposed children: health to 3 years of age.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Prenatally buprenorphine-exposed children: health to 3 years of age.
@en
type
label
Prenatally buprenorphine-exposed children: health to 3 years of age.
@en
prefLabel
Prenatally buprenorphine-exposed children: health to 3 years of age.
@en
P2093
P2860
P1476
Prenatally buprenorphine-exposed children: health to 3 years of age.
@en
P2093
Kaisa Kivistö
Sarimari Tupola
Satu Kivitie-Kallio
P2860
P2888
P304
P356
10.1007/S00431-015-2562-0
P577
2015-05-24T00:00:00Z